Founders
The Center for Computational and Integrative Biology was founded by
a group of MGH researchers and Harvard professors. Click on any of the
names to link to a page with more complete information about each of them.
|
| Fred
Ausubel |
Frederick M. Ausubel is Professor of Genetics at Harvard
Medical School and the Ernst Winnacker Distinguished Investigator
in the Department of Molecular Biology at Massachusetts General Hospital.
Dr. Ausubel’s scientific work focuses primarily on host-microbe
interactions.
Dr. Ausubel was elected to the National Academy of Sciences in 1994,
the American Academy of Microbiology in 2002, and the American Academy
of Arts and Sciences in 2003. In addition to serving on a variety
of editorial boards, Dr. Ausubel is founding editor of the widely-read
Current Protocols in Molecular Biology. |
 |
 |
|
| Mason Freeman |
Dr. Freeman graduated from Harvard College and received his M.D.
at the University of California, San Francisco in 1979. He served
as an intern, resident, and endocrinology fellow in the Department
of Medicine at the Massachusetts General Hospital and was Chief Resident
in Medicine at the MGH in 1985. Following clinical training, he worked
as a post-doctoral research fellow in the Biology Department of the
Massachusetts Institute of Technology before returning to the MGH
to head the Cardiovascular Health Center. He became Chief of the Lipid
Metabolism Unit at the MGH in 1992. Mason’s research work has
centered on the role of macrophages in atherosclerosis with particular
interest in the trafficking of lipids through these cells. |
|
 |
|
| Brian Seed |
Dr. Seed is Director of the Center for Computational and Integrative
Biology at the Massachusetts General Hospital and is Professor of
Genetics at Harvard . A graduate of CalTech, he received both his
B.S. and Ph.D. degrees there. Dr. Seed is the author of numerous publications
molecular biology, genomics and proteomics. He holds numerous patents;
see the CV for a list.
His laboratories include groups in automation, bioinformatics,
chemistry, microarrays, proteomics, selection, sequencing and synthesis,
in addition to his own Seed Lab.
|
|
 |
|
| Jack Szostak
|
Dr. Szostak is an Investigator of the Howard Hughes Medical Institute,
Professor of Genetics at Harvard Medical School, and the Alex Rich
Distinguished Investigator in the Department of Molecular Biology
at the Massachusetts General Hospital. His current research interests
are in the laboratory synthesis of self-replicating systems and the
origin of life. Dr. Szostak is a member of the National Academy of
Sciences, and a Fellow of the New York Academy of Sciences and the
American Academy of Arts and Sciences.
In 2000, Dr. Szostak was awarded the Medal of the Genetics Society
of America. |
|
 |
|
| Ron
Tompkins |
Ron Tompkins graduated Summa Cum Laude from Tulane University Medical
School and holds a doctorate in chemical and biomedical engineering
from the Massachusetts Institute of Technology.
Dr. Tompkins is the Chief of Burns Service at the Massachusetts
General Hospital, is the John Frances Burke Professor of Surgery
at Harvard Medical School, and serves as the Chief of Staff of Shriners
Hospital for Children in Boston. Dr. Tompkins' primary research
interests are in physiology of inflammation and burn healing. |
|
 |
|
| Jia Wolfe |
Dr. Wolfe has extensive research and management experience in the
biotech industry and has a special interest in drug discovery and
interdisciplinary research in chemistry and biology. She currently
directs a drug discovery group within the Center for Computational
and Integrative Biology. An honors graduate of University of Science
and Technology of China, Jia received broad training there, including
chemistry, mathematics, physics, and statistics.
Dr. Wolfe has published many peer-reviewed research articles in prestigious
chemistry and biology journals, and is an inventor of more than ten
issued US patents. |
|
 |
|
| Ramnik Xavier |
Ramnik Xavier is Assistant Professor of Medicine at Harvard Medical
School and attending physician in the Gastrointestinal Unit at Massachusetts
General Hospital.
He is Board certified in Medicine and Gastroenterology. Following
clinical training, he completed his post-doctoral fellowship with
Brian Seed in the Department of Molecular Biology at the MGH Department
of Genetics at Harvard Medical School. While in the Seed lab, Ramnik
and his colleagues demonstrated that lipid rafts play an important
role in T cell signaling. His current research focuses on PDZ proteins
in cell signaling and genomic approaches for dissecting novel pathways
in inflammation and cancer. |
|
 |
| |
|